Laurus Labs invests Rs. 80 crore in cell & gene therapy firm ImmunoACT.

Laurus Labs on Wednesday invested further Rs 80 crore in the Immunoadoptive Cell Therapy Private Ltd. (lmmunoACT), that's developing an affordable CAR T-cell therapy for curing specific types of blood cancers.

Laurus will get an additional stake of 7.24% in ImmunoACT, as part of Series-B funding. Post the completion of the latest round of funding, Laurus stake in ImmunoACT will increase to 33.86% (on a fully diluted basis).

ET